Regenxbio logo

Regenxbio Share Price Today

(NASDAQ: RGNX)

Regenxbio share price is $6.25 & ₹543.56 as on 6 Mar 2025, 2.30 'hrs' IST

$6.25

0.33

(5.57%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Regenxbio share price in Dollar and Rupees. Guide to invest in Regenxbio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Regenxbio, along with analyst recommendations, forecasts, and comprehensive financials.

Regenxbio share price movements

  • Today's Low: $5.86
    Today's High: $6.26

    Day's Volatility :6.47%

  • 52 Weeks Low: $5.86
    52 Weeks High: $28.80

    52 Weeks Volatility :79.65%

Regenxbio (RGNX) Returns

PeriodRegenxbio IncSector (Health Care)Index (Russel 2000)
3 Months
-32.27%
2.1%
0.0%
6 Months
-47.98%
-4.1%
0.0%
1 Year
-75.33%
2.2%
0.0%
3 Years
-78.5%
11.8%
-11.6%

Regenxbio (RGNX) Key Statistics

in dollars & INR

Previous Close
$5.92
Open
$5.93
Today's High
$6.26
Today's Low
$5.855
Market Capitalization
$293.3M
Today's Volume
$280.4K
52 Week High
$28.8
52 Week Low
$5.855
Revenue TTM
$84.3M
EBITDA
$-223.6M
Earnings Per Share (EPS)
$-5.01
Profit Margin
-283.19%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-71.87%

How to invest in Regenxbio Stock (RGNX) from India?

It is very easy for Indian residents to invest directly in Regenxbio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Regenxbio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Regenxbio or RGNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Regenxbio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Regenxbio shares which would translate to 0.139 fractional shares of Regenxbio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Regenxbio, in just a few clicks!

Returns in Regenxbio (RGNX) for Indian investors in Rupees

The Regenxbio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Regenxbio investment value today

Current value as on today

₹31,004

Returns

₹68,996

(-69%)

Returns from Regenxbio Stock

₹73,958 (-73.96%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Regenxbio (RGNX)

-58%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Regenxbio Stock from India on INDmoney has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Regenxbio

  • BlackRock Inc

    11.03%

  • Redmile Group, LLC

    9.68%

  • JPMorgan Chase & Co

    8.35%

  • Vanguard Group Inc

    6.03%

  • State Street Corp

    4.41%

  • Morgan Stanley - Brokerage Accounts

    4.04%

Analyst Recommendation on Regenxbio

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Regenxbio(by analysts ranked 0 to 5 stars)

Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
12
Hold
2
2
4
Sell
0
0
0

Analyst Forecast on Regenxbio Stock (RGNX)

What analysts predicted

Upside of 426.67%

Target:

$32.92

Current:

$6.25

Insights on Regenxbio Stock (Ticker Symbol: RGNX)

  • Price Movement

    In the last 1 month, RGNX stock has moved down by -29.8%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 15.62M → 24.19M (in $), with an average increase of 18.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -52.98M → -59.59M (in $), with an average decrease of 12.5% per quarter
  • RGNX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 138.2%
  • RGNX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 126.3%
  • Price to Sales

    ForRGNX every $1 of sales, investors are willing to pay $3.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Regenxbio Technicals Summary

Sell

Neutral

Buy

Regenxbio is currently in a neutral trading position according to technical analysis indicators.

Regenxbio (RGNX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Regenxbio Inc logo
-24.3%
-47.98%
-75.33%
-78.5%
-83.41%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Regenxbio Inc logo
12.06
NA
0.26
-4.76
-0.72
-0.26
NA
6.09
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Regenxbio Inc logo
Buy
$293.3M
-83.41%
12.06
-283.19%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Regenxbio

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
Organization
Regenxbio
Employees
344
CEO
Mr. Curran M. Simpson M.S.
Industry
Health Technology

Management People of Regenxbio

NameTitle
Mr. Curran M. Simpson M.S.
President, CEO & Director
Dr. Olivier Danos Ph.D.
Executive VP & Chief Scientific Officer
Dr. Stephen Pakola M.D.
Executive VP & Chief Medical Officer
Mr. Mitchell Chan M.B.A.
Executive VP & CFO
Mr. Patrick J. Christmas II, J.D.
Executive VP & Chief Legal Officer
Ms. Shiva G. Fritsch
Chief Communications & People Officer
Dr. Ram Palanki Pharm.D.
Executive VP of Commercial Strategy & Operations

Important FAQs about investing in RGNX Stock from India :

What is Regenxbio share price today?

Regenxbio share price today stands at $6.25, Open: $5.93 ; Previous Close: $5.92 ; High: $6.26 ; Low: $5.86 ; 52 Week High: $28.80 ; 52 Week Low: $5.86.

The stock opens at $5.93, after a previous close of $5.92. The stock reached a daily high of $6.26 and a low of $5.86, with a 52-week high of $28.80 and a 52-week low of $5.86.

Can Indians buy Regenxbio shares?

Yes, Indians can invest in the Regenxbio (RGNX) from India.

With INDmoney, you can buy Regenxbio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Regenxbio at zero transaction cost.

How can I buy Regenxbio shares from India?

It is very easy to buy Regenxbio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Regenxbio (RGNX) be purchased?

Yes, you can buy fractional shares of Regenxbio with INDmoney app.

What are the documents required to start investing in Regenxbio stocks?

To start investing in Regenxbio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Regenxbio Stock (RGNX)?

Today’s highest price of Regenxbio (RGNX) is $6.26.

Today’s lowest price of Regenxbio (RGNX) is $5.86.

What is today's market capitalisation of Regenxbio?

Today's market capitalisation of Regenxbio RGNX is 293.3M

What is the 52 Week High and Low Range of Regenxbio Stock (RGNX)?

  • 52 Week High

    $28.80

  • 52 Week Low

    $5.86

What are the historical returns of Regenxbio (RGNX)?

  • 1 Month Returns

    -24.3%

  • 3 Months Returns

    -47.98%

  • 1 Year Returns

    -75.33%

  • 5 Years Returns

    -83.41%

Who is the Chief Executive Officer (CEO) of Regenxbio ?

Mr. Curran M. Simpson M.S. is the current Chief Executive Officer (CEO) of Regenxbio.